MCFT
MasterCraft Boat Holdings, Inc.
MCFT trails on the overall score without a compensating advantage in the available component scores.
NIO
NIO Inc.
NIO has the edge over MCFT overall, supported by stronger modeled upside and lower modeled downside.
MCFT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Strong |
MCFT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
MCFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $1.21 | -94% |
| Fair | 9.3x | $1.67 | -92% |
| Expensive | 24x | $4.36 | -80% |
| Current | 120x | $21.59 | — |
Historical ranges are pointers, not guarantees.
MCFT's PE is in its expensive range at 120x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
MCFT Forward outlook
There aren't enough analyst estimates for MCFT to show an outlook.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
MCFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -81% |
| Q2 2026 | -$0.10 | -123% |
| Q1 2026 | $0.68 | +$1.05 |
| Q4 2025 | $0.96 | +$1.34 |
| Q3 2025 | $0.97 | +$1.18 |
| Q2 2025 | $0.44 | -4.3% |
| Q1 2025 | -$0.37 | -117% |
| Q4 2024 | -$0.38 | -112% |
MCFT has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
MCFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.1M | +123% |
| Q2 2026 | $129.9M | +63% |
| Q1 2026 | $78.2M | +3% |
| Q4 2025 | $71.8M | +13% |
| Q3 2025 | $69M | +5.6% |
| Q2 2025 | $79.5M | +18% |
| Q1 2025 | $76M | -21% |
| Q4 2024 | $63.4M | -36% |
MCFT's revenue is recovering but still below its 2022 peak: $154M last quarter, up 123% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +2.3 points |
| Q2 2026 | -4.9% | -12 points |
| Q1 2026 | -1.7% | -7.1 points |
| Q4 2025 | 3.8% | +3.5 points |
| Q3 2025 | 5.5% | +3.9 points |
| Q2 2025 | 7.5% | +25 points |
| Q1 2025 | 5.4% | +1.2 points |
| Q4 2024 | 0.3% | -6.8 points |
MCFT has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over MCFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
MCFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$12.8M |
| Q2 2026 | $14.6M | -18% |
| Q1 2026 | $3.8M | -13% |
| Q4 2025 | $14M | +245% |
| Q3 2025 | -$9.9M | -5083% |
| Q2 2025 | $17.9M | +$31.4M |
| Q1 2025 | $4.3M | +$5.2M |
| Q4 2024 | $4M | -83% |
MCFT still generates free cash flow, though less than at its 2023 peak: $35M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
MCFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -3.5x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -8.8x | Net Cash |
| Q4 2024 | -10.1x | Net Cash |
MCFT has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MCFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 32.4 | Neutral |
MCFT's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
MCFT PE vs Consumer Cyclical Sector
| Metric | MCFT | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 18x | 565% above |
| PE % | 100 | 47 | 53 pts above |
MCFT is trading at 120x earnings, a 565% premium to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
MCFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 6.1% above |
| 20 week MA | $22.3 | 3.2% below |
| 50 week MA | $22.1 | 2.4% below |
| 100 week MA | $20.5 | 5.2% above |
| 200 week MA | $22.0 | 1.8% below |
MCFT has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
MCFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $26.7 | +73% |
| 2021 | $26.7 | $26.3 | -1.6% |
| 2022 | $26.3 | $26.2 | -0.3% |
| 2023 | $26.2 | $22.6 | -14% |
| 2024 | $22.6 | $18.7 | -17% |
| 2025 | $18.7 | $19.5 | +4.1% |
| 2026 YTD | $19.5 | $21.6 | +11% |
MCFT has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.